Form 4 for TNDM TANDEM DIABETES CARE INC
Accepted 2021-08-31 00:00:00 ET · period of report 2021-08-27 · accession 0001438133-21-000151 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-31 | 2021-08-27 | TNDM | Leal James | SVP, Ops | F - Tax | $0.00 | -154 | 3,751 | -4% | $0 |
| DM | 2021-08-31 | 2021-08-27 | TNDM | Leal James | SVP, Ops | M - OptEx | $43.45 | +1,976 | 5,418 | +57% | +$85.9K |
| DM | 2021-08-31 | 2021-08-27 | TNDM | Leal James | SVP, Ops | S - Sale+OE | $110.64 | -1,667 | 3,918 | -30% | -$184.4K |
| DM | 2021-08-31 | 2021-08-27 | TNDM | Leal James | SVP, Ops | M - OptEx | $43.45 | +1,976 | 3,407 | +138% | +$85.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-27 | F | D | 154 | $0.00 | 3,751 | D | — | — | |
| 2 | Common | Common Stock | 2021-08-27 | M | A | 309 | $0.00 | 3,905 | D | — | — | |
| 3 | Common | Common Stock | 2021-08-27 | S | D | 167 | $111.12 | 3,751 | D | — | — | |
| 4 | Common | Common Stock | 2021-08-27 | M | A | 1,667 | $51.50 | 5,418 | D | — | — | |
| 5 | Common | Common Stock | 2021-08-27 | S | D | 1,500 | $110.59 | 3,918 | D | — | — | (F4) The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $110.00 to $110.98. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. |
| 6 | Derivative | Stock Option | 2021-08-27 | M | A | 1,667 | $51.50 | 30,000 | D | $51.50 · — to — | 1,667 Common Stock | (F8) The options vested as to twenty-five (25%) of the underlying shares on 2/15/2020, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). (F9) The expiration date for these options is 10 years from the date of grant. |
| 7 | Derivative | Restricted Stock Unit | 2021-08-27 | M | A | 309 | $0.00 | 3,407 | D | — · — to — | 309 Common Stock | (F5) Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan). (F6) Each RSU represents a contingent right to receive one share of common stock of the Company. (F7) RSU vested as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. |